SoftMedx Healthcare Limited (SoftMedx) reported that its issued share capital remained unchanged for the month ended 31 October 2026. The number of ordinary shares in issue stood at 107.12 million, with zero treasury shares held.
The company confirmed compliance with the Hong Kong Main Board’s minimum public-float requirement—set at 25% of issued shares—indicating that at least one-quarter of SoftMedx’s equity continues to trade freely in the market.
No movements were recorded across all capital-changing instruments: • Authorised or registered share capital: no alterations. • Share options, warrants, convertibles, and other share-issuing arrangements: none reported during the month. • Treasury share transactions, repurchases, or cancellations: none.
The filing, dated 3 November 2026, was submitted by Company Secretary Leung Ka Ho, affirming that all regulatory and listing-rule obligations have been duly observed.
Comments